CHIP Clinic's goals: Research, preventive care
Study suggests limited role for CET in this cancer type
Study assesses outcomes of therapies with novel agents
Autologous anti-CD19 agent produces impressive survival improvements
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Interim results of phase 2 trial are promising
Targeting pyrimidine synthesis inhibits GSC self-renewal and tumorigenesis
Study affirms XRT’s utility
Relapse more likely with faster PSA doubling time
Results prompt clinical practice change
Cleveland Clinic-led research employs advanced image analysis to inform dose delivery
Advertisement
Advertisement